Clinical Trial Update: Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating paclitaxel plus carboplatin with or without Endostar in advanced non-small cell lung cancer has completed. The document provides trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Endostar (recombinant human endostatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd | Conditions: Advanced Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED